Stanley Laman Group, Ltd. Laboratory Corp Of America Holdings Transaction History

Stanley Laman Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$120.82 - $174.09 $3.68 Million - $5.3 Million	-30,425 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$167.67 - $188.27 $360,993 - $405,345	-2,153 Reduced 6.61%	30,425 $5.28 Million
Q2 2018 Aug 09, 2018	BUY	$160.33 - $189.41 $135,318 - $159,862	844 Added 2.66%	32,578 $5.85 Million
Q1 2018 May 01, 2018	SELL	$161.53 - $178.11 $191,897 - $211,594	-1,188 Reduced 3.61%	31,734 $5.13 Million
Q4 2017 Feb 09, 2018	BUY	$147.99 - $163.95 $232,344 - $257,401	1,570 Added 5.01%	32,922 $5.25 Million
Q3 2017 Nov 13, 2017	BUY	$149.47 - $160.56 $4.69 Million - $5.03 Million	31,352	31,352 $4.73 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.